Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. - Nagourney,R.A.; Brewer,C.A.; Radecki,S.; Kidder,W.A.; Sommers,B.L.; Evans,S.S.; Minor,D.R.; DiSaia,P.J. (Gynecol Oncol, 2003)